Experimental myocardial stem cell therapy for ST-elevation myocardial infarction: rationale and level of evidence.

MLA

Kastrup, Jens, et al. “Experimental Myocardial Stem Cell Therapy for ST-Elevation Myocardial Infarction: Rationale and Level of Evidence.” Minerva Cardioangiologica, vol. 64, no. 3, June 2016, pp. 322–29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26899403&authtype=sso&custid=ns315887.

APA

Kastrup, J., Mygind, N. D., Qayyum, A. A., & Mathiasen, A. B. (2016). Experimental myocardial stem cell therapy for ST-elevation myocardial infarction: rationale and level of evidence. Minerva Cardioangiologica, 64(3), 322–329.

Chicago

Kastrup, Jens, Naja D Mygind, Abbas A Qayyum, and Anders B Mathiasen. 2016. “Experimental Myocardial Stem Cell Therapy for ST-Elevation Myocardial Infarction: Rationale and Level of Evidence.” Minerva Cardioangiologica 64 (3): 322–29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26899403&authtype=sso&custid=ns315887.